Candel Therapeutics (NASDAQ:CADL) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM.
Here’s what investors need to know about the announcement.
Earnings
Candel Therapeutics missed estimated earnings by -138.0%, reporting an EPS of $-0.38 versus an estimate of $-0.16.
Revenue was down $31 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 4.0% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Candel Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
